This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Chirotech Technology Limited, Dr. Reddy's Laboratories, Incorporated. Active years: 2001-2011.
Company Filing History:

Years Active: 2001-2011
Title: The Innovations of Philip Mark Jackson
Introduction
Philip Mark Jackson is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of chemistry, particularly in the development of catalysts and intermediates for pharmaceutical applications. With a total of 3 patents to his name, Jackson's work has had a meaningful impact on various chemical processes.
Latest Patents
One of his latest patents is focused on bisphospholanes for use as catalysts in asymmetric reactions. This invention concerns an enantiomerically enriched compound of formula (1) or the opposite enantiomer, wherein each of Ar—Ar represents the same or different aromatic groups of up to 20 carbon atoms. The bridging group X is defined by the formula (5), in which * denotes points of attachment to phosphorus atoms, along with methods of making these compounds. Another significant patent involves an intermediate for the synthesis of prostaglandins, showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Jackson has worked with prominent companies in the pharmaceutical industry, including Dr. Reddy's Laboratories and Chirotech Technology Limited. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance chemical research and development.
Collaborations
Jackson has collaborated with several professionals in his field, including Ian Campbell Lennon and Martin E Fox. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective areas of expertise.
Conclusion
Philip Mark Jackson's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in chemical processes and pharmaceutical applications.